Il Dong Pharmaceutical Co Ltd (249420) — Capital Reinvestment Ratio
Il Dong Pharmaceutical Co Ltd (249420) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩11.28 Billion) in capital expenditures (₩5.97 Billion). See 249420 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Il Dong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Il Dong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 6 annual periods. Check total reinvestment intensity of Il Dong Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Il Dong Pharmaceutical Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see 249420 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | ₩28.29 Billion | ₩14.05 Billion | ▼ -33.0% |
| 2020 | 0.74x | ₩19.37 Billion | ₩14.35 Billion | ▲ +154.2% |
| 2019 | 0.29x | ₩41.37 Billion | ₩12.06 Billion | ▲ +28.8% |
| 2018 | 0.23x | ₩66.65 Billion | ₩15.09 Billion | ▼ -0.2% |
| 2017 | 0.23x | ₩73.72 Billion | ₩16.73 Billion | ▼ -26.6% |
| 2016 | 0.31x | ₩45.98 Billion | ₩14.22 Billion | — |